Clinical Trial Update: Lipo-prostaglandin E1 Improves Renal Hypoxia Evaluated by BOLD-MRI in Patients With Diabetic Nephropathy [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial found that Lipo-prostaglandin E1 improved renal oxygenation in patients with diabetic nephropathy, as measured by BOLD-MRI; results hav…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Nephropathy

Drugs mentioned

• Lipo-prostaglandin E1 (prostaglandin E1 (alprostadil))

Snippet

Sponsor: West China Hospital | Conditions: Diabetic Nephropathy | Phase 4 | Status: COMPLETED | Results posted: 2016-05-24